II Medinol Ltd v. Abbott Ireland and Abbot Vascular International BCBA & Others, High Court, Commercial List Dublin (High Court, Commercial List Dublin), 27 May 2011

Kluwer Patent Blog
October 15, 2012

Please refer to this post as: , ‘II Medinol Ltd v. Abbott Ireland and Abbot Vascular International BCBA & Others, High Court, Commercial List Dublin (High Court, Commercial List Dublin), 27 May 2011’, Kluwer Patent Blog, October 15 2012, http://patentblog.kluweriplaw.com/2012/10/15/ii-medinol-ltd-v-abbott-ireland-and-abbot-vascular-international-bcba-others-high-court-commercial-list-dublin-high-court-commercial-list-dublin-27-may-2011/


The Court cited the parallel proceedings between the parties in the United Kingdom, where the approach of the EPO Board of Appeal in T331/87 Houdaille/Removal of Feature [1991] EPOR 194 was applied, and concluded that the changes in the patent amount to added matter.

Click here for the full text of this case.

A summary of this case will be posted on http://www.KluwerIPCases.com